HomeTagsSystemic Mastocytosis

Systemic Mastocytosis

Sanofi Acquires Blueprint Medicines to Boost Immunology Pipeline

Sanofi announced a definitive agreement to acquire Blueprint Medicines Corporation, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and other KIT-driven diseases. This...

Blueprint Medicines Reports Clinical Data Highlighting Leadership in Developing Targeted Treatment Options

Blueprint Medicines Corporation announced AYVAKIT data showing high, durable response rates and prolonged overall survival (OS) in patients with advanced systemic mastocytosis (Advanced SM),...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics